chr19-13209459-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001127222.2(CACNA1A):​c.6379G>A​(p.Val2127Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000147 in 1,363,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 1.31

Publications

0 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.058272302).
BP6
Variant 19-13209459-C-T is Benign according to our data. Variant chr19-13209459-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 476271.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.6379G>A p.Val2127Met missense_variant Exon 45 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.6382G>A p.Val2128Met missense_variant Exon 45 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.6379G>A p.Val2127Met missense_variant Exon 45 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.6382G>A p.Val2128Met missense_variant Exon 45 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.6397G>A p.Val2133Met missense_variant Exon 46 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.6385G>A p.Val2129Met missense_variant Exon 45 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.6382G>A p.Val2128Met missense_variant Exon 45 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.6382G>A p.Val2128Met missense_variant Exon 45 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.6346G>A p.Val2116Met missense_variant Exon 44 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.6241G>A p.Val2081Met missense_variant Exon 44 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.6382G>A p.Val2128Met missense_variant Exon 45 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.6397G>A p.Val2133Met missense_variant Exon 46 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.6388G>A p.Val2130Met missense_variant Exon 46 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.6385G>A p.Val2129Met missense_variant Exon 45 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.6382G>A p.Val2128Met missense_variant Exon 45 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.6346G>A p.Val2116Met missense_variant Exon 44 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.*645G>A non_coding_transcript_exon_variant Exon 43 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*1558G>A non_coding_transcript_exon_variant Exon 45 of 47 ENSP00000519091.1
CACNA1AENST00000636768.2 linkn.*645G>A 3_prime_UTR_variant Exon 43 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*1558G>A 3_prime_UTR_variant Exon 45 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152078
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000445
AC:
3
AN:
67394
AF XY:
0.0000559
show subpopulations
Gnomad AFR exome
AF:
0.000396
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000192
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000107
AC:
13
AN:
1210980
Hom.:
0
Cov.:
32
AF XY:
0.00000686
AC XY:
4
AN XY:
582872
show subpopulations
African (AFR)
AF:
0.000157
AC:
4
AN:
25442
American (AMR)
AF:
0.00
AC:
0
AN:
15116
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16272
East Asian (EAS)
AF:
0.0000325
AC:
1
AN:
30772
South Asian (SAS)
AF:
0.0000230
AC:
1
AN:
43426
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41916
Middle Eastern (MID)
AF:
0.000224
AC:
1
AN:
4474
European-Non Finnish (NFE)
AF:
0.00000406
AC:
4
AN:
984540
Other (OTH)
AF:
0.0000408
AC:
2
AN:
49022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152078
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.000169
AC:
7
AN:
41418
American (AMR)
AF:
0.00
AC:
0
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68002
Other (OTH)
AF:
0.00
AC:
0
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.546
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000523
Hom.:
0
Bravo
AF:
0.0000793
ESP6500AA
AF:
0.000251
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000178
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Dec 20, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.6382G>A (p.V2128M) alteration is located in exon 45 (coding exon 45) of the CACNA1A gene. This alteration results from a G to A substitution at nucleotide position 6382, causing the valine (V) at amino acid position 2128 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
19
DANN
Benign
0.95
DEOGEN2
Benign
0.019
.;.;T;.;.;.;.;.;T;.;.;T;.;.;.;T;.;.
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.55
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.78
T;T;T;T;D;T;T;T;T;D;.;T;T;T;T;T;D;D
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.058
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.41
.;.;.;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
1.3
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-0.85
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.25
Sift
Benign
0.074
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.075
T;T;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.27
MVP
0.79
MPC
0.27
ClinPred
0.050
T
GERP RS
0.91
Varity_R
0.094
gMVP
0.31
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368183370; hg19: chr19-13320273; API